mirtazapine has been researched along with Cat Diseases in 6 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Cat Diseases: Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mirtazapine is classified as a weight gain drug in cats, and the purpose of this study was to evaluate its efficacy in cats experiencing unintended weight loss." | 9.30 | A double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss. ( Buhles, W; Hu, T; Labelle, D; Poole, M; Quimby, JM, 2019) |
| "Mirtazapine is classified as a weight gain drug in cats, and the purpose of this study was to evaluate its efficacy in cats experiencing unintended weight loss." | 5.30 | A double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss. ( Buhles, W; Hu, T; Labelle, D; Poole, M; Quimby, JM, 2019) |
| "Cats with chronic kidney disease (CKD) often experience inappetence and vomiting and might benefit from the administration of mirtazapine, a medication with appetite stimulant and anti-nausea properties." | 5.17 | Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial. ( Lunn, KF; Quimby, JM, 2013) |
| "Liver disease (LD) prolongs mirtazapine half-life in humans, but it is unknown if this occurs in cats with LD and healthy cats." | 1.48 | In vivo and in vitro assessment of mirtazapine pharmacokinetics in cats with liver disease. ( Benson, KK; Fitzpatrick, RL; Gustafson, DL; Quimby, JM; Ramirez, D; Sieberg, LG; Wittenburg, LA, 2018) |
| " The objectives of this study were to determine the most common adverse effects reported and the dose associated with these signs." | 1.43 | Mirtazapine toxicity in cats: retrospective study of 84 cases (2006-2011). ( Bates, JA; Ferguson, LE; McLean, MK; Quimby, JM, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wyatt, D | 1 |
| Santoro, D | 1 |
| Deabold, K | 1 |
| Gruntmeir, J | 1 |
| Childress, A | 1 |
| Craft, WF | 1 |
| Walden, HDS | 1 |
| Wellehan, JFX | 1 |
| Fitzpatrick, RL | 1 |
| Quimby, JM | 5 |
| Benson, KK | 2 |
| Ramirez, D | 1 |
| Sieberg, LG | 1 |
| Wittenburg, LA | 1 |
| Gustafson, DL | 2 |
| Poole, M | 1 |
| Hu, T | 1 |
| Labelle, D | 1 |
| Buhles, W | 1 |
| Summers, SC | 1 |
| Saffire, A | 1 |
| Herndon, AK | 1 |
| Bai, S | 1 |
| Lunn, KF | 1 |
| Ferguson, LE | 1 |
| McLean, MK | 1 |
| Bates, JA | 1 |
3 trials available for mirtazapine and Cat Diseases
| Article | Year |
|---|---|
A double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss.
Topics: Administration, Cutaneous; Animals; Appetite Stimulants; Cat Diseases; Cats; Double-Blind Method; Fe | 2019 |
Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease.
Topics: Administration, Cutaneous; Animals; Appetite Stimulants; Cat Diseases; Cats; Double-Blind Method; Mi | 2020 |
Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial.
Topics: Animals; Anorexia; Antiemetics; Appetite Stimulants; Cat Diseases; Cats; Cross-Over Studies; Female; | 2013 |
3 other studies available for mirtazapine and Cat Diseases
| Article | Year |
|---|---|
Subcutaneous nodules and dermatitis associated with non-
Topics: Animals; Anorexia; Antidepressive Agents; Cat Diseases; Cats; Dermatitis; Dirofilaria; Dirofilariasi | 2020 |
In vivo and in vitro assessment of mirtazapine pharmacokinetics in cats with liver disease.
Topics: Animals; Appetite Stimulants; Case-Control Studies; Cat Diseases; Cats; Female; Half-Life; In Vitro | 2018 |
Mirtazapine toxicity in cats: retrospective study of 84 cases (2006-2011).
Topics: Animals; Appetite Stimulants; Cat Diseases; Cats; Drug-Related Side Effects and Adverse Reactions; F | 2016 |